Centenial Surgical Suture News

Centenial Surgical Suture Flags Price Manipulation

Centenial Surgical Suture Ltd responds to BSE surveillance inquiry, alleging systematic price manipulation through suspicious trading patterns involving small lot transactions across multiple investors.

Centenial Surgical Files BSE Complaint on Price Manipulation

Centenial Surgical Suture Ltd files formal complaint with BSE alleging unusual trading activities and price manipulation in scrip 531308 during February 06-13, 2026 period.

Centenial Surgical Suture Approves Q3FY26 Results

Centenial Surgical Suture Ltd. board approves standalone unaudited financial results for quarter and nine months ended December 31, 2025, following regulatory compliance requirements.

Centennial Surgical Suture Reports Quarterly Financial Results for September 2025

Centennial Surgical Suture Ltd approved its standalone un-audited financial results for the quarter and half year ended September 30, 2025, along with statements of assets and liabilities and cash flow statements. The Board of Directors meeting held on November 13, 2025 also approved these financial documents which were reviewed by the audit committee and statutory auditors.

Surgical Suture Ltd Appoints Neel Vora to Audit Committee

Surgical Suture Ltd reconstituted its Audit Committee by appointing Neel Vora, an Independent Non-Executive Director, as a new member effective October 10, 2025. The Board of Directors passed a Circular Resolution to make this appointment. The reconstituted Audit Committee now comprises four members: Akash Modi (Chairman, Independent Non-Executive Director), Ridhima Limaye (Member, Independent Non-Executive Director), Neel Vora (Member, Independent Non-Executive Director), and Vijay Majrekar (Member, Managing Director).